Barely Significant
← all excerpts

Nintedanib in Combination With Chemotherapy in the Treatment of Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Cureus · 2024 · PMC10924634 · PMID 38465177

Europe PMCDOI
1
hedged sentence
0.0300
closest p · 0.6× alpha
0.0300
boldest claim

The sentences

barely significantP = 0.03actually significant
In the present study, ORR ​​is barely significant [RR = 1.22; 95% CI [1.02 to 1.46]; P = 0.03].

also in 113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.